Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent

Purinergic receptor is a potential drug target for neuropathic pain, Alzheimer disease, and prostate cancer. Focusing on the structure-based ligand discovery, docking analysis on the crystal structure of P2Y(1) receptor (P2Y(1)R) with 923 derivatives of 1-indolinoalkyl 2-phenolic compound is perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Hien Thi Thu, Rimpilainen, Tatu, Konda Mani, Saravanan, Murugesan, Akshaya, Yli-Harja, Olli, Candeias, Nuno R., Kandhavelu, Meenakshisundaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908675/
https://www.ncbi.nlm.nih.gov/pubmed/31831761
http://dx.doi.org/10.1038/s41598-019-55194-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908675/
https://www.ncbi.nlm.nih.gov/pubmed/31831761
http://dx.doi.org/10.1038/s41598-019-55194-8

Ejemplares similares